stars 1 stars 2 stars 3

At Mediomics, we strive to help scientists and researchers discover new drugs. We are an innovative life sciences company specializing in homogeneous assay kits. Our goal is to make the lives of scientists and researchers easier. Our focus is quick and easy assay kits, high affinity binding reagents, and biosensors for detecting biologically and therapeutically important macromolecules, biomarkers, and pathogens. These kits are valuable resources for scientists in the pharmaceutical, biopharmaceutical, and biotechnology industries, as well as university, hospital, and national laboratory researchers. Our platform Bridge-It, FRET-PINCER, and TRF-PINCER technologies have already been adapted for the detection of a range of important macromolecules, including cAMP, tryptophan, S-adenosyl methionine, PDE, biotin, insulin, C-peptide, albumin, C-reactive protein (hCRP), IgG, IgM, E. coli, and others.

Mediomics, LLC Questions

The Mediomics, LLC annual revenue was $11 million in 2026.

Yie-Hwa Chang is the Founder of Mediomics, LLC.

4 people are employed at Mediomics, LLC.

Mediomics, LLC is based in St. Louis, Missouri.

The NAICS codes for Mediomics, LLC are [541714, 541, 5417, 54, 54171].

The SIC codes for Mediomics, LLC are [87, 873].

Top Mediomics, LLC Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users